Consolidated Statements of Net Income (Loss) and Comprehensive Income (Loss) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
REVENUES
Total revenues	$ 12,537	$ 8,965	$ 33,820	$ 25,299
OPERATING COSTS AND EXPENSES
Cost of goods sold	2,475	550	5,447	843
License royalties			100	210
Research and development	22,453	23,131	71,785	64,488
Selling, general, and administrative	13,626	13,988	50,146	39,433
Total operating costs and expenses	38,554	37,669	127,478	104,974
Loss from operations	(26,017)	(28,704)	(93,658)	(79,675)
OTHER INCOME / (LOSS), NET
Gain from sale of priority review voucher, net				62,010
Interest and other loss	(1,509)	(154)	(3,067)	(717)
NET LOSS	(27,526)	(28,858)	(96,725)	(18,382)
Other comprehensive income
Foreign currency translation	1,598	238	3,331	751
COMPREHENSIVE LOSS	$ (25,928)	$ (28,620)	$ (93,394)	$ (17,631)
Net income / (loss) per share attributable to common stockholders, basic (in dollars per share)	$ (0.63)	$ (0.66)	$ (2.21)	$ (0.43)
Net income / (loss) per share attributable to common stockholders, diluted (in dollars per share)	$ (0.63)	$ (0.66)	$ (2.21)	$ (0.43)
Weighted average common shares outstanding, basic (in shares)	43,718,351	43,598,350	43,715,451	43,019,217
Weighted average common shares outstanding, diluted (in shares)	43,718,351	43,598,350	43,715,451	43,019,217
Product
REVENUES
Total revenues	$ 12,537	$ 8,965	$ 32,820	$ 23,299
License
REVENUES
Total revenues			$ 1,000	$ 2,000